Patient Recruitment Accelerator

80%

Of trials fail enrolment
timelines

40%

Of study delays related to difficult patient recruitment

30%

Of the product lifecycle is spent in patient recruitment


Why daCRO?

This new paradigm offers the Pharmaceutical Industry and Clinical Research Organisations (CROs) a strategic partnership with the commercial arm of the European Cancer Network

daCRO can reach thousands of oncologists in 39 countries in over 10,000 Health Centres, 1,000 Institutions and hundreds of study groups

Let us help shorten your drug development time

500x500